“This settlement is another step in our ongoing effort to reset our company and we applaud the Attorney General’s plan to deploy resources to address underage use. We will continue working with federal and state stakeholders to advance a fully regulated, science-based marketplace for vapor products. As part of that process, we will continue to support Tobacco 21 and enforcement against illicit and illegally marketed products, such as certain disposables, that jeopardize the harm reduction potential of alternative vapor products.
We remain in ongoing discussions with other key stakeholders about litigation related to our past as part of our commitment to earn trust.”
To read the full consent order, please click here.
October 2, 2024
On September 26th, Juul Labs’ Chairman & Chief Executive Officer, K.C. Crosthwaite, delivered the keynote address at the 2024 Global Tobacco & Nicotine Forum,…
July 29, 2024
Juul Labs announced today the settlement with a group of noteholders that confirms the conversion of the convertible notes to equity, and provides an…
June 6, 2024
Today, the FDA rescinded its June 2022 Marketing Denial Orders (MDOs) for the JUUL System and placed our applications back into scientific review. We appreciate the FDA’s decision and now look forward to re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization for JUUL products.